Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Malek

Showing results (81-90 of 112) with videos related to

Pageof 12
Sort By:
Gene Therapy|April 17, 2009
VSV virotherapy improves chemotherapy by triggering apoptosis due to proteasomal degradation of Mcl-1P Schache, E Gürlevik, N Strüver, et al.
Blood|November 1, 2007
Comprehensive biomarker and genomic analysis identifies p53 status as the major determinant of response to MDM2 inhibitors in chronic lymphocytic leukemiaChris Saddler, Peter Ouillette, Lisa Kujawski, et al.
Scientific Reports|August 4, 2019
The Genomic Landscape of Centromeres in CancersAnjan K Saha, Mohamad Mourad, Mark H Kaplan, et al.
Blood|October 13, 2011
Somatic mutations in the transcriptional corepressor gene BCORL1 in adult acute myelogenous leukemiaMeng Li, Roxane Collins, Yuchen Jiao, et al.
Leukemia|February 26, 2011
p53 stabilization induces apoptosis in chronic myeloid leukemia blast crisis cellsL F Peterson, E Mitrikeska, D Giannola, et al.
Blood|July 29, 2011
Acquired genomic copy number aberrations and survival in chronic lymphocytic leukemiaPeter Ouillette, Roxane Collins, Sajid Shakhan, et al.
Zeitschrift Fur Gastroenterologie|January 18, 2022
S Voesch, M Bitzer, S Blödt, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 11, 2011
A pathobiological role of the insulin receptor in chronic lymphocytic leukemiaKamlai Saiya-Cork, Roxane Collins, Brian Parkin, et al.
Leukemia|October 25, 2024
Aberrant BCAT1 expression augments MTOR activity and accelerates disease progression in chronic lymphocytic leukemiaQiangqiang Shao, Jedrzej Wykretowicz, Nan Hu, et al.
Leukemia|November 13, 2024
Correction: Aberrant BCAT1 expression augments MTOR activity and accelerates disease progression in chronic lymphocytic leukemiaQiangqiang Shao, Jedrzej Wykretowicz, Nan Hu, et al.
Pageof 12

Showing results (81-90 of 112) with videos related to

Sort By:
Pageof 12
Gene Therapy|April 17, 2009
VSV virotherapy improves chemotherapy by triggering apoptosis due to proteasomal degradation of Mcl-1P Schache, E Gürlevik, N Strüver, et al.
Blood|November 1, 2007
Comprehensive biomarker and genomic analysis identifies p53 status as the major determinant of response to MDM2 inhibitors in chronic lymphocytic leukemiaChris Saddler, Peter Ouillette, Lisa Kujawski, et al.
Scientific Reports|August 4, 2019
The Genomic Landscape of Centromeres in CancersAnjan K Saha, Mohamad Mourad, Mark H Kaplan, et al.
Blood|October 13, 2011
Somatic mutations in the transcriptional corepressor gene BCORL1 in adult acute myelogenous leukemiaMeng Li, Roxane Collins, Yuchen Jiao, et al.
Leukemia|February 26, 2011
p53 stabilization induces apoptosis in chronic myeloid leukemia blast crisis cellsL F Peterson, E Mitrikeska, D Giannola, et al.
Blood|July 29, 2011
Acquired genomic copy number aberrations and survival in chronic lymphocytic leukemiaPeter Ouillette, Roxane Collins, Sajid Shakhan, et al.
Zeitschrift Fur Gastroenterologie|January 18, 2022
S Voesch, M Bitzer, S Blödt, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 11, 2011
A pathobiological role of the insulin receptor in chronic lymphocytic leukemiaKamlai Saiya-Cork, Roxane Collins, Brian Parkin, et al.
Leukemia|October 25, 2024
Aberrant BCAT1 expression augments MTOR activity and accelerates disease progression in chronic lymphocytic leukemiaQiangqiang Shao, Jedrzej Wykretowicz, Nan Hu, et al.
Leukemia|November 13, 2024
Correction: Aberrant BCAT1 expression augments MTOR activity and accelerates disease progression in chronic lymphocytic leukemiaQiangqiang Shao, Jedrzej Wykretowicz, Nan Hu, et al.
Pageof 12